Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers (Q45737847)
Jump to navigation
Jump to search
scientific article published on 10 April 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers |
scientific article published on 10 April 2001 |
Statements
1 reference
Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers (English)
1 reference
1 reference
C Celum
1 reference
R B Belshe
1 reference
G J Gorse
1 reference
K Weinhold
1 reference
S Frey
1 reference
C Stevens
1 reference
S Buchbinder
1 reference
H Sheppard
1 reference
D Stablein
1 reference
S Self
1 reference
J McNamara
1 reference
J Flores
1 reference
J L Excler
1 reference
M Klein
1 reference
R E Habib
1 reference
A M Duliege
1 reference
C Harro
1 reference
L Corey
1 reference
M Keefer
1 reference
M Mulligan
1 reference
P Wright
1 reference
F Judson
1 reference
K Mayer
1 reference
D McKirnan
1 reference
G Woody
1 reference
National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group and HIV Network for Prevention Trials (HIVNET)
1 reference
10 April 2001
1 reference
1 reference
183
1 reference
9
1 reference
1343-1352
1 reference
Identifiers
1 reference
1 reference